Theoretically, an anti-cytokine approach can be used to protect against bleeding in damaged joints; however, limited studies have shown that intervention of the cytokine network may serve as a novel therapeutic direction [5,29,30,31]; this includes our previous study with anti-IL-6 in hemophilia A mice [8]. The gene discussed is IL6; the disease is hemophilia.